Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mitsui Global Investments (MGI) is the venture capital subsidiary of Mitsui & Co., Ltd., a global trading and investment conglomerate. The firm specializes in identifying and supporting high-growth startups across the healthcare, life sciences, and technology sectors. MGI provides capital, strategic guidance, and access to Mitsui's extensive global network to help portfolio companies achieve international scale. Its healthcare investments span biotechnology, medical devices, and digital health, focusing on transformative innovations that address significant unmet medical needs. By leveraging global resources, MGI helps its portfolio companies scale operations and enter new markets, particularly in Asia and the United States. The firm maintains a presence in key innovation hubs, including Silicon Valley and Tokyo, to identify and support emerging leaders in the life sciences industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mitsui Global Investments.